Article · 18 Dec 2025
Conference abstract
Tuberculosis a diagnostic dilemma: Experience in a developing endemic country
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis remains one the leading killers among the infectious diseases. According to the WHO estimates, one-third of the world?s population remains infected with the silent killer; Mycobacterium tuberculosis. One in ten latent infections progresses to active tuberculosis. 95% of infections occur in the developing countries where diagnostic and treatment facilities are scarce. Pakistan ranks fifth among the high tuberculosis burden countries with incidence rate of 181/100,000 and prevalence 359/100,000 population. Poverty, dislodgment, overcrowding and lack of awareness add greatly to the burden as three-fourths of victims remain undiagnosed. The emerging threat of multidrug resistant tuberculosis and extensively drug resistant tuberculosis is compounding the problem; hindering TB control measures and further challenging the developing nations. Worldwide, around 400,000 cases of MDR TB are detected annually with mortality rates between 50-80%. The mortality occurs within 14-16 weeks of diagnosis. Prevalence of MDR primary cases is 1.3% and 13% in previously treated cases. Studies have indicated MDR-TB frequency around 30% in our country. We have conducted a number of studies concentrating on techniques affordable for developing countries including direct microscopy of sputum for AFB; Mantoux test; role of Quantiferon TB Gold for endemic country; recovery rate of MTB through BACTEC MGIT 960; first and second line anti-TB drug testing; thin layer agar (TLA) experience; fine needle aspiration sample for comparing cytology and polymerase chain reaction in cases of extrapulmonary tuberculosis. The valuable experience over the years with these modalities will be shared.
Keywords
Subjects
MicrobiologyInfectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Microbiology: Open Access.
Article · 18 Dec 2025
Culture-Based and Molecular Assessment of Microbial Diversity
Article · 18 Dec 2025
Antimicrobial Resistance Detection and Microbial Identification
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Microbiology: Open Access
- SubjectMicrobiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Aamer Ikram”
